Q4 2024 Earnings Call Transcript February 19, 2025 Amicus Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

Ionis Pharmaceuticals, Inc. today announced that it will present additional data from the pivotal Phase 3 OASIS and OASISplus studies, as well as three year data from the Phase 2 open-label extension ...

DOGE reportedly overvalued several areas of government spending that it claimed to have eliminated. Has it actually “saved” ...

Broad Institute to collaborate on flagship project tapping Illumina's new spatial technology At AGBT, customers will present data demonstrating unparalleled scale and sensitivity in research spanning ...

FYB202 is an interleukin inhibitor that can be used in dermatology to treat psoriasis and in gastroenterology to treat chronic inflammatory bowel disease. The biosimilar received marketing ...

President Donald Trump is moving to give the White House direct control of independent federal regulators such as the ...

James Arthur McDonald Jr., 53, a frequent guest on CNBC financial news shows, ran investment businesses in LA and Redondo ...

The U.S. Securities and Exchange Commission has been overhauling its digital asset legal strategy, and this week it dropped an appeal of the crypto dealer rule.

The SEC's Republican leaders have shifted what had been a crypto-focused enforcement squad into a smaller group with a ...

The executive order doesn’t explicitly mention enforcement, but observers expect that the assertion of total authority over ...